Pills
The Belgrade Galenika company announced on April 21 that it had produced and given the Serbian Cabinet 372,000 Hydroxychloroquine sulfate pills worth EUR400,000.
The full amount will be delivered to the Serbian Republican Fund for Health Insurance over the the next several days.
Galenika company director Ricardo Vian Marque has said that the company is investing efforts into securing the continuity of deliveries and making citizens feel safe about the availability of the drug.
"The production and donation of Hydroxychloroquine is our contribution" to the common fight against the coronavirus pandemic and "our wish as a socially responsible company to help the Serbian healthcare system," Marques said.
The technology used to produce Hydroxychloroquine was secured by the Brazilian EMB company, which owns Galenika Beograd. Last month, the EMS company from Brazil launched clinical trials to test how effective the drug was in treating patients with Covid-19.
To get full access to all content of interest see our
Subscription offer
Or
Register for free
And read up to 5 articles each month.
Already have an account? Please Log in.